AEVI GENOMIC Revenue, Profits - GNMX Annual Income Statement

Add to My Stocks
$1.14 $0.08 (6.56%) GNMX stock closing price Jun 21, 2018 (Closing)

Looking at financial statements, along with the AEVI GENOMIC stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2017 impacts the GNMX stock. Investors typically check year over year or quarter over quarter revenue growth. The operating expenses as shown in the AEVI GENOMIC profit and loss statement for 2017 total to $34.69M. This line item shows that the operating expenses has decreased compared with last year. Also check: AEVI GENOMIC assets and AEVI GENOMIC free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
AEVI GENOMIC Revenues or Net Sales
-------
Cost Of Goods Sold (COGS)-------
AEVI GENOMIC Gross Profit
-------
Research & Development Expense25.17M28.35M23.61M8.25M7.29M5.43M5.05M
Selling General & Admin Expense9.52M13.52M12.95M10.68M10.52M7.19M4.92M
Income Before Depreciation Depletion Amortization-34.7M-41.87M-36.56M-18.93M-17.81M-12.62M-9.97M
Depreciation Depletion Amortization-------
Non Operating Income-0.01M-0.01M-1.4M---2.42M1.88M
Interest Expense-------
AEVI GENOMIC Pretax Income
-34.71M-41.88M-37.97M-18.42M-17.11M-15.05M-8.09M
Provision for Income Taxes-------
MinorityInterest-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations-34.71M-41.9M-37.99M-18.43M-17.12M-15.07M-8.09M
Extraordinary Items & Discontinued Operations-------
AEVI GENOMIC Profit/ Loss (Net Income)
-34.71M-41.9M-37.99M-18.43M-17.12M-15.07M-8.09M
Average Shares used to compute Diluted EPS41.68M35.16M25.08M19.29M17.68M11.02M8.45M
Average Shares used to compute Basic EPS41.68M35.16M25.02M19.25M17.63M11.02M8.45M
Income Before Nonrecurring Items-34.71M-41.9M-29.82M-18.43M-17.13M-15.07M-8.1M
Income from Nonrecurring Items---8.17M----
AEVI GENOMIC Earnings Per Share Basic Net
-0.83-1.19-1.52-0.96-0.97-1.37-0.96
AEVI GENOMIC Earnings Per Share Diluted Net
-0.83-1.19-1.55-1.00-1.06-1.37-0.96
EPS Diluted Before Nonrecurring Items-0.83-1.19-1.22-1.00-1.06-1.37-0.96
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

AEVI GENOMIC stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2017. Our AEVI GENOMIC revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-34.71M for GNMX stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the GNMX income statement, one can check the AEVI GENOMIC historical stock prices to check how the price has moved with time.

AEVI GENOMIC Income Statement - Key Financial Ratios